Financhill
Back

Apellis Pharmaceuticals Vs. Braze Industry Stock Comparison

Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
35.63
Seasonality Move:
15.53%
Sell
23

BRZE
Braze

Last Price:
35.03
Seasonality Move:
-2.96%
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $35.53. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
23
Braze (BRZE) is a Sell

Is Braze a Buy, Sell or Hold?

  • The current Braze [BRZE] share price is $35.60. The Score for BRZE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • BRZE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $35.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.

BRZE Stock Price Chart

What is Braze's stock price today?

  • The Braze share price today is $35.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BRZE is experiencing slight buying pressure.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.33 Sell
Relative Strength Index (14 RSI): 39.84 Sell
Chaikin Money Flow: -728829 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.93 - 39.81) Sell
Bollinger Bands (100): (36.69 - 43.03) Sell

BRZE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.85 Sell
Relative Strength Index (14 RSI): 36.45 Sell
Chaikin Money Flow: 215605 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.76 - 45.1) Sell
Bollinger Bands (100): (36.81 - 42.95) Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.1 Sell
20-day SMA: 38.7 Sell
50-day SMA: 38.06 Sell
200-day SMA: 50.38 Sell
8-day EMA: 37.4 Sell
20-day EMA: 38.04 Sell
50-day EMA: 38.67 Sell
200-day EMA: 46.02 Sell

BRZE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.14 Buy
20-day SMA: 40.69 Sell
50-day SMA: 40.51 Sell
200-day SMA: 45.87 Sell
8-day EMA: 36.34 Sell
20-day EMA: 38.77 Sell
50-day EMA: 39.99 Sell
200-day EMA: 42.69 Sell

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.71 per share, an increase next quarter of $0.24 per share, an increase this year of $3.17 per share, and an increase next year of $1.50 per share.

Braze Earnings Growth & BRZE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.06 per share, an increase this year of $0.42 per share, and an increase next year of $0.33 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Braze Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):